English

MACROGENICS, INC.

EDGAR

MGNX Current report (8-K) · filed 2026-10-23

Annual consolidated revenue for 2025: about USD 149.5M, using the latest reported figures. The previous period, 2024, was about USD 150M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

32.8 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 32832000 USD Source

Operating margin

-42.19%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -13852000 USD Source
Revenue: 32832000 USD Source

Operating cash flow

-40.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -76559000 USD Source
Operating Cash Flow: -35811000 USD Source

Free cash flow

-41.6 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -76559000 USD Source
Operating Cash Flow: -35811000 USD Source
Capital Expenditure: 1150000 USD Source
Capital Expenditure: 344000 USD Source

Cash and cash equivalents: 114 million USD 2026-06-30 Source
Exact value

113907000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 63.6 million shares 2026-06-30 Source
Exact value

63645711 shares

Reported share-count change

0.70% · 440 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

63205703 shares · 2025-06-30· Source
63645711 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-23.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-0.3%

Prior period

USD 149.96 million

2024-01-01 – 2024-12-31
Current period

USD 149.5 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

149500000 − 149962000 = -462000 USD

149962000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
149500000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Year-over-year change in Revenue: -462000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 149500000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1624779 Filing: 000112534526000017 Input fundies:Revenue: 149962000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1625621 Filing: 000112534526000017
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 7.65 million

Prior period

−USD 66.97 million

2024-01-01 – 2024-12-31
Current period

−USD 74.62 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-74620000 − -66966000 = -7654000 USD

-66966000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-74620000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Year-over-year change in Net income: -7654000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -74620000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1657441 Filing: 000112534526000017 Input fundies:NetIncome: -66966000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1658382 Filing: 000112534526000017
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 12.67 million

Prior period

−USD 68.37 million

2024-01-01 – 2024-12-31
Current period

−USD 81.04 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-81040000 − -68373000 = -12667000 USD

-68373000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-81040000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Year-over-year change in Operating cash flow: -12667000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -81040000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1089047 Filing: 000112534526000017 Input fundies:OperatingCashFlow: -68373000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1089698 Filing: 000112534526000017
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-48.4%

Prior period

USD 3.71 million

2024-01-01 – 2024-12-31
Current period

USD 1.91 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1914000 − 3706000 = -1792000 USD

3706000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1914000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Year-over-year change in Capital expenditure: -1792000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1914000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1096752 Filing: 000112534526000017 Input fundies:CapitalExpenditure: 3706000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1097341 Filing: 000112534526000017
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 149.5 million 100% of revenue
Operating costs Derived USD 222.34 million 149% of revenue
Operating income −USD 72.84 million −49% of revenue
Tax, interest and other Derived USD 1.78 million 1.2% of revenue
Net income −USD 74.62 million −50% of revenue

Cash

Operating cash flow −USD 81.04 million −54% of revenue
Capital expenditure USD 1.91 million 1.3% of revenue
Free cash flow Derived −USD 82.95 million −55% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 165% of revenue.
2017 Operating loss: operating costs were 114% of revenue.
2018 Operating loss: operating costs were 385% of revenue.
2019 Operating loss: operating costs were 376% of revenue.
2020 Operating loss: operating costs were 225% of revenue.
2021 Operating loss: operating costs were 362% of revenue.
2022 Operating loss: operating costs were 180% of revenue.
2023 Operating loss: operating costs were 386% of revenue.
2024 Operating loss: operating costs were 174% of revenue.
2025 Operating loss: operating costs were 149% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	91880000	151922000 Derived	-60042000	-1514000 Derived	-58528000	-55060000 Derived	Source 2016-01-01 – 2016-12-31: 91880000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -60042000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -58528000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -43679000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 11381000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	157742000	179885000 Derived	-22143000	-2517000 Derived	-19626000	-14998000 Derived	Source 2017-01-01 – 2017-12-31: 157742000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -22143000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -19626000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 14405000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 29403000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	60121000	231327000 Derived	-171206000	247000 Derived	-171453000	-178188000 Derived	Source 2018-01-01 – 2018-12-31: 60121000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -171206000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -171453000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -153234000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 24954000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	64188000	241373000 Derived	-177185000	-25374000 Derived	-151811000	-138559000 Derived	Source 2019-01-01 – 2019-12-31: 64188000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -177185000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -151811000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -134270000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 4289000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	104883000	235943000 Derived	-131060000	-1321000 Derived	-129739000	-117804000 Derived	Source 2020-01-01 – 2020-12-31: 104883000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -131060000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -129739000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -111898000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 5906000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	77447000	280242000 Derived	-202795000	-680000 Derived	-202115000	-150031000 Derived	Source 2021-01-01 – 2021-12-31: 77447000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -202795000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -202115000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -143830000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 6201000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	151941000	273359000 Derived	-121418000	-1660000 Derived	-119758000	-90582000 Derived	Source 2022-01-01 – 2022-12-31: 151941000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -121418000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -119758000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -86959000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 3623000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	58749000	226993000 Derived	-168244000	-159186000 Derived	-9058000	-79969000 Derived	Source 2023-01-01 – 2023-12-31: 58749000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -168244000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -9058000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -78205000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1764000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	149962000	260540000 Derived	-110578000	-43612000 Derived	-66966000	-72079000 Derived	Source 2024-01-01 – 2024-12-31: 149962000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -110578000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -66966000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -68373000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 3706000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	149500000	222341000 Derived	-72841000	1779000 Derived	-74620000	-82954000 Derived	Source 2025-01-01 – 2025-12-31: 149500000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -72841000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -74620000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -81040000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 1914000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 149.5M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	91880000	Revenue: 91880000 Open source
20172017-12-31	Revenue	157742000	Revenue: 157742000 Open source
20182018-12-31	Revenue	60121000	Revenue: 60121000 Open source
20192019-12-31	Revenue	64188000	Revenue: 64188000 Open source
20202020-12-31	Revenue	104883000	Revenue: 104883000 Open source
20212021-12-31	Revenue	77447000	Revenue: 77447000 Open source
20222022-12-31	Revenue	151941000	Revenue: 151941000 Open source
20232023-12-31	Revenue	58749000	Revenue: 58749000 Open source
20242024-12-31	Revenue	149962000	Revenue: 149962000 Open source
20252025-12-31	Revenue	149500000	Revenue: 149500000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-0.3% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	-8.9%	Revenue: 91880000 Open source Revenue: 100854000 Open source
20172017-12-31	Year over year	71.7%	Revenue: 157742000 Open source Revenue: 91880000 Open source
20182018-12-31	Year over year	-61.9%	Revenue: 60121000 Open source Revenue: 157742000 Open source
20192019-12-31	Year over year	6.8%	Revenue: 64188000 Open source Revenue: 60121000 Open source
20202020-12-31	Year over year	63.4%	Revenue: 104883000 Open source Revenue: 64188000 Open source
20212021-12-31	Year over year	-26.2%	Revenue: 77447000 Open source Revenue: 104883000 Open source
20222022-12-31	Year over year	96.2%	Revenue: 151941000 Open source Revenue: 77447000 Open source
20232023-12-31	Year over year	-61.3%	Revenue: 58749000 Open source Revenue: 151941000 Open source
20242024-12-31	Year over year	155.3%	Revenue: 149962000 Open source Revenue: 58749000 Open source
20252025-12-31	Year over year	-0.3%	Revenue: 149500000 Open source Revenue: 149962000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -48.7% 2025

Net margin -49.9% 2025

Free cash flow margin -55.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-65.3%	Operating Income: -60042000 Open source Revenue: 91880000 Open source
20172017-12-31	Operating margin	-14%	Operating Income: -22143000 Open source Revenue: 157742000 Open source
20182018-12-31	Operating margin	-284.8%	Operating Income: -171206000 Open source Revenue: 60121000 Open source
20192019-12-31	Operating margin	-276%	Operating Income: -177185000 Open source Revenue: 64188000 Open source
20202020-12-31	Operating margin	-125%	Operating Income: -131060000 Open source Revenue: 104883000 Open source
20212021-12-31	Operating margin	-261.9%	Operating Income: -202795000 Open source Revenue: 77447000 Open source
20222022-12-31	Operating margin	-79.9%	Operating Income: -121418000 Open source Revenue: 151941000 Open source
20232023-12-31	Operating margin	-286.4%	Operating Income: -168244000 Open source Revenue: 58749000 Open source
20242024-12-31	Operating margin	-73.7%	Operating Income: -110578000 Open source Revenue: 149962000 Open source
20252025-12-31	Operating margin	-48.7%	Operating Income: -72841000 Open source Revenue: 149500000 Open source
20162016-12-31	Net margin	-63.7%	Net Income: -58528000 Open source Revenue: 91880000 Open source
20172017-12-31	Net margin	-12.4%	Net Income: -19626000 Open source Revenue: 157742000 Open source
20182018-12-31	Net margin	-285.2%	Net Income: -171453000 Open source Revenue: 60121000 Open source
20192019-12-31	Net margin	-236.5%	Net Income: -151811000 Open source Revenue: 64188000 Open source
20202020-12-31	Net margin	-123.7%	Net Income: -129739000 Open source Revenue: 104883000 Open source
20212021-12-31	Net margin	-261%	Net Income: -202115000 Open source Revenue: 77447000 Open source
20222022-12-31	Net margin	-78.8%	Net Income: -119758000 Open source Revenue: 151941000 Open source
20232023-12-31	Net margin	-15.4%	Net Income: -9058000 Open source Revenue: 58749000 Open source
20242024-12-31	Net margin	-44.7%	Net Income: -66966000 Open source Revenue: 149962000 Open source
20252025-12-31	Net margin	-49.9%	Net Income: -74620000 Open source Revenue: 149500000 Open source
20162016-12-31	Free cash flow margin	-59.9%	Revenue: 91880000 Open source Operating Cash Flow: -43679000 Open source Capital Expenditure: 11381000 Open source
20172017-12-31	Free cash flow margin	-9.5%	Revenue: 157742000 Open source Operating Cash Flow: 14405000 Open source Capital Expenditure: 29403000 Open source
20182018-12-31	Free cash flow margin	-296.4%	Revenue: 60121000 Open source Operating Cash Flow: -153234000 Open source Capital Expenditure: 24954000 Open source
20192019-12-31	Free cash flow margin	-215.9%	Revenue: 64188000 Open source Operating Cash Flow: -134270000 Open source Capital Expenditure: 4289000 Open source
20202020-12-31	Free cash flow margin	-112.3%	Revenue: 104883000 Open source Operating Cash Flow: -111898000 Open source Capital Expenditure: 5906000 Open source
20212021-12-31	Free cash flow margin	-193.7%	Revenue: 77447000 Open source Operating Cash Flow: -143830000 Open source Capital Expenditure: 6201000 Open source
20222022-12-31	Free cash flow margin	-59.6%	Revenue: 151941000 Open source Operating Cash Flow: -86959000 Open source Capital Expenditure: 3623000 Open source
20232023-12-31	Free cash flow margin	-136.1%	Revenue: 58749000 Open source Operating Cash Flow: -78205000 Open source Capital Expenditure: 1764000 Open source
20242024-12-31	Free cash flow margin	-48.1%	Revenue: 149962000 Open source Operating Cash Flow: -68373000 Open source Capital Expenditure: 3706000 Open source
20252025-12-31	Free cash flow margin	-55.5%	Revenue: 149500000 Open source Operating Cash Flow: -81040000 Open source Capital Expenditure: 1914000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -81M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-43679000	Operating Cash Flow: -43679000 Open source
20172017-12-31	Operating cash flow	14405000	Operating Cash Flow: 14405000 Open source
20182018-12-31	Operating cash flow	-153234000	Operating Cash Flow: -153234000 Open source
20192019-12-31	Operating cash flow	-134270000	Operating Cash Flow: -134270000 Open source
20202020-12-31	Operating cash flow	-111898000	Operating Cash Flow: -111898000 Open source
20212021-12-31	Operating cash flow	-143830000	Operating Cash Flow: -143830000 Open source
20222022-12-31	Operating cash flow	-86959000	Operating Cash Flow: -86959000 Open source
20232023-12-31	Operating cash flow	-78205000	Operating Cash Flow: -78205000 Open source
20242024-12-31	Operating cash flow	-68373000	Operating Cash Flow: -68373000 Open source
20252025-12-31	Operating cash flow	-81040000	Operating Cash Flow: -81040000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -83M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-55060000	Operating Cash Flow: -43679000 Open source Capital Expenditure: 11381000 Open source
20172017-12-31	Free cash flow	-14998000	Operating Cash Flow: 14405000 Open source Capital Expenditure: 29403000 Open source
20182018-12-31	Free cash flow	-178188000	Operating Cash Flow: -153234000 Open source Capital Expenditure: 24954000 Open source
20192019-12-31	Free cash flow	-138559000	Operating Cash Flow: -134270000 Open source Capital Expenditure: 4289000 Open source
20202020-12-31	Free cash flow	-117804000	Operating Cash Flow: -111898000 Open source Capital Expenditure: 5906000 Open source
20212021-12-31	Free cash flow	-150031000	Operating Cash Flow: -143830000 Open source Capital Expenditure: 6201000 Open source
20222022-12-31	Free cash flow	-90582000	Operating Cash Flow: -86959000 Open source Capital Expenditure: 3623000 Open source
20232023-12-31	Free cash flow	-79969000	Operating Cash Flow: -78205000 Open source Capital Expenditure: 1764000 Open source
20242024-12-31	Free cash flow	-72079000	Operating Cash Flow: -68373000 Open source Capital Expenditure: 3706000 Open source
20252025-12-31	Free cash flow	-82954000	Operating Cash Flow: -81040000 Open source Capital Expenditure: 1914000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

78.4% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	13.7%	Total Liabilities: 42512000 Open source Total Assets: 311263000 Open source
20172017-12-31	Liabilities / assets	20%	Total Liabilities: 74645000 Open source Total Assets: 373883000 Open source
20182018-12-31	Liabilities / assets	26.9%	Total Liabilities: 89253000 Open source Total Assets: 332130000 Open source
20192019-12-31	Liabilities / assets	26.2%	Total Liabilities: 81873000 Open source Total Assets: 312501000 Open source
20202020-12-31	Liabilities / assets	21.9%	Total Liabilities: 82859000 Open source Total Assets: 378743000 Open source
20212021-12-31	Liabilities / assets	28.5%	Total Liabilities: 95627000 Open source Total Assets: 335245000 Open source
20222022-12-31	Liabilities / assets	49.4%	Total Liabilities: 138455000 Open source Total Assets: 280468000 Open source
20232023-12-31	Liabilities / assets	48.9%	Total Liabilities: 145805000 Open source Total Assets: 298418000 Open source
20242024-12-31	Liabilities / assets	55.6%	Total Liabilities: 145598000 Open source Total Assets: 261655000 Open source
20252025-12-31	Liabilities / assets	78.4%	Total Liabilities: 201255000 Open source Total Assets: 256846000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.1× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	10.4×	Current Assets: 283947000 Open source Current Liabilities: 27302000 Open source
20172017-12-31	Current assets / current liabilities	6.48×	Current Assets: 322298000 Open source Current Liabilities: 49755000 Open source
20182018-12-31	Current assets / current liabilities	4.49×	Current Assets: 269124000 Open source Current Liabilities: 59940000 Open source
20192019-12-31	Current assets / current liabilities	5.31×	Current Assets: 239785000 Open source Current Liabilities: 45167000 Open source
20202020-12-31	Current assets / current liabilities	6.17×	Current Assets: 312594000 Open source Current Liabilities: 50673000 Open source
20212021-12-31	Current assets / current liabilities	3.75×	Current Assets: 279560000 Open source Current Liabilities: 74578000 Open source
20222022-12-31	Current assets / current liabilities	4.57×	Current Assets: 222180000 Open source Current Liabilities: 48611000 Open source
20232023-12-31	Current assets / current liabilities	4.48×	Current Assets: 251339000 Open source Current Liabilities: 56108000 Open source
20242024-12-31	Current assets / current liabilities	3.92×	Current Assets: 217490000 Open source Current Liabilities: 55530000 Open source
20252025-12-31	Current assets / current liabilities	5.1×	Current Assets: 219941000 Open source Current Liabilities: 43115000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 58.53 million Exact value Exact value: -58528000 USD 2016-01-01 – 2016-12-31: -58528000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2016-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -58528000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58528000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534519000046/mgnx-20181231.htm#1275976 Filing: 000112534519000046 The citation records this snapshot. The page link may show a newer release later.	−USD 43.68 million Exact value Exact value: -43679000 USD 2016-01-01 – 2016-12-31: -43679000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2016-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -43679000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43679000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534519000046/mgnx-20181231.htm#1314593 Filing: 000112534519000046 The citation records this snapshot. The page link may show a newer release later.	USD 11.38 million Exact value Exact value: 11381000 USD 2016-01-01 – 2016-12-31: 11381000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2016-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 11381000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11381000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534519000046/mgnx-20181231.htm#1326716 Filing: 000112534519000046 The citation records this snapshot. The page link may show a newer release later.	−USD 55.06 million Calculation and evidence -43679000 − 11381000 USD Exact free cash flow: -55060000 USD 2016-01-01 – 2016-12-31: -43679000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 11381000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2016-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -55060000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -43679000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534519000046/mgnx-20181231.htm#1314593 Filing: 000112534519000046 Input fundies:CapitalExpenditure: 11381000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534519000046/mgnx-20181231.htm#1326716 Filing: 000112534519000046 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 19.63 million Exact value Exact value: -19626000 USD 2017-01-01 – 2017-12-31: -19626000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2017-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -19626000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19626000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534520000031/mgnx-20191231.htm#1409805 Filing: 000112534520000031 The citation records this snapshot. The page link may show a newer release later.	USD 14.41 million Exact value Exact value: 14405000 USD 2017-01-01 – 2017-12-31: 14405000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2017-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: 14405000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 14405000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534520000031/mgnx-20191231.htm#1462435 Filing: 000112534520000031 The citation records this snapshot. The page link may show a newer release later.	USD 29.4 million Exact value Exact value: 29403000 USD 2017-01-01 – 2017-12-31: 29403000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2017-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 29403000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29403000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534520000031/mgnx-20191231.htm#1477353 Filing: 000112534520000031 The citation records this snapshot. The page link may show a newer release later.	−USD 15 million Calculation and evidence 14405000 − 29403000 USD Exact free cash flow: -14998000 USD 2017-01-01 – 2017-12-31: 14405000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 29403000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2017-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -14998000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 14405000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534520000031/mgnx-20191231.htm#1462435 Filing: 000112534520000031 Input fundies:CapitalExpenditure: 29403000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534520000031/mgnx-20191231.htm#1477353 Filing: 000112534520000031 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 171.45 million Exact value Exact value: -171453000 USD 2018-01-01 – 2018-12-31: -171453000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2018-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -171453000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -171453000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534521000035/mgnx-20201231.htm#1151552 Filing: 000112534521000035 The citation records this snapshot. The page link may show a newer release later.	−USD 153.23 million Exact value Exact value: -153234000 USD 2018-01-01 – 2018-12-31: -153234000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2018-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -153234000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -153234000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534521000035/mgnx-20201231.htm#1191908 Filing: 000112534521000035 The citation records this snapshot. The page link may show a newer release later.	USD 24.95 million Exact value Exact value: 24954000 USD 2018-01-01 – 2018-12-31: 24954000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2018-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 24954000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24954000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534521000035/mgnx-20201231.htm#1203088 Filing: 000112534521000035 The citation records this snapshot. The page link may show a newer release later.	−USD 178.19 million Calculation and evidence -153234000 − 24954000 USD Exact free cash flow: -178188000 USD 2018-01-01 – 2018-12-31: -153234000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 24954000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2018-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -178188000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -153234000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534521000035/mgnx-20201231.htm#1191908 Filing: 000112534521000035 Input fundies:CapitalExpenditure: 24954000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534521000035/mgnx-20201231.htm#1203088 Filing: 000112534521000035 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 151.81 million Exact value Exact value: -151811000 USD 2019-01-01 – 2019-12-31: -151811000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2019-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -151811000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -151811000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534522000013/mgnx-20211231.htm#1136288 Filing: 000112534522000013 The citation records this snapshot. The page link may show a newer release later.	−USD 134.27 million Exact value Exact value: -134270000 USD 2019-01-01 – 2019-12-31: -134270000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2019-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -134270000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -134270000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534522000013/mgnx-20211231.htm#1182970 Filing: 000112534522000013 The citation records this snapshot. The page link may show a newer release later.	USD 4.29 million Exact value Exact value: 4289000 USD 2019-01-01 – 2019-12-31: 4289000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2019-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 4289000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4289000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534522000013/mgnx-20211231.htm#1194210 Filing: 000112534522000013 The citation records this snapshot. The page link may show a newer release later.	−USD 138.56 million Calculation and evidence -134270000 − 4289000 USD Exact free cash flow: -138559000 USD 2019-01-01 – 2019-12-31: -134270000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 4289000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2019-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -138559000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -134270000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534522000013/mgnx-20211231.htm#1182970 Filing: 000112534522000013 Input fundies:CapitalExpenditure: 4289000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534522000013/mgnx-20211231.htm#1194210 Filing: 000112534522000013 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 129.74 million Exact value Exact value: -129739000 USD 2020-01-01 – 2020-12-31: -129739000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2020-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -129739000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -129739000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000059/mgnx-20221231.htm#1122914 Filing: 000112534523000059 The citation records this snapshot. The page link may show a newer release later.	−USD 111.9 million Exact value Exact value: -111898000 USD 2020-01-01 – 2020-12-31: -111898000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2020-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -111898000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -111898000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000059/mgnx-20221231.htm#1155497 Filing: 000112534523000059 The citation records this snapshot. The page link may show a newer release later.	USD 5.91 million Exact value Exact value: 5906000 USD 2020-01-01 – 2020-12-31: 5906000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2020-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 5906000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5906000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000059/mgnx-20221231.htm#1163707 Filing: 000112534523000059 The citation records this snapshot. The page link may show a newer release later.	−USD 117.8 million Calculation and evidence -111898000 − 5906000 USD Exact free cash flow: -117804000 USD 2020-01-01 – 2020-12-31: -111898000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5906000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2020-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -117804000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -111898000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000059/mgnx-20221231.htm#1155497 Filing: 000112534523000059 Input fundies:CapitalExpenditure: 5906000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534523000059/mgnx-20221231.htm#1163707 Filing: 000112534523000059 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 202.12 million Exact value Exact value: -202115000 USD 2021-01-01 – 2021-12-31: -202115000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2021-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -202115000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -202115000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534524000060/mgnx-20231231.htm#1092375 Filing: 000112534524000060 The citation records this snapshot. The page link may show a newer release later.	−USD 143.83 million Exact value Exact value: -143830000 USD 2021-01-01 – 2021-12-31: -143830000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2021-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -143830000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -143830000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534524000060/mgnx-20231231.htm#1130348 Filing: 000112534524000060 The citation records this snapshot. The page link may show a newer release later.	USD 6.2 million Exact value Exact value: 6201000 USD 2021-01-01 – 2021-12-31: 6201000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2021-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 6201000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6201000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534524000060/mgnx-20231231.htm#1138028 Filing: 000112534524000060 The citation records this snapshot. The page link may show a newer release later.	−USD 150.03 million Calculation and evidence -143830000 − 6201000 USD Exact free cash flow: -150031000 USD 2021-01-01 – 2021-12-31: -143830000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 6201000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2021-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -150031000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -143830000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534524000060/mgnx-20231231.htm#1130348 Filing: 000112534524000060 Input fundies:CapitalExpenditure: 6201000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534524000060/mgnx-20231231.htm#1138028 Filing: 000112534524000060 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 119.76 million Exact value Exact value: -119758000 USD 2022-01-01 – 2022-12-31: -119758000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2022-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -119758000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -119758000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534525000042/mgnx-20241231.htm#1715111 Filing: 000112534525000042 The citation records this snapshot. The page link may show a newer release later.	−USD 86.96 million Exact value Exact value: -86959000 USD 2022-01-01 – 2022-12-31: -86959000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2022-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -86959000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -86959000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534525000042/mgnx-20241231.htm#1129195 Filing: 000112534525000042 The citation records this snapshot. The page link may show a newer release later.	USD 3.62 million Exact value Exact value: 3623000 USD 2022-01-01 – 2022-12-31: 3623000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2022-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 3623000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3623000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534525000042/mgnx-20241231.htm#1136873 Filing: 000112534525000042 The citation records this snapshot. The page link may show a newer release later.	−USD 90.58 million Calculation and evidence -86959000 − 3623000 USD Exact free cash flow: -90582000 USD 2022-01-01 – 2022-12-31: -86959000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 3623000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2022-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -90582000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -86959000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534525000042/mgnx-20241231.htm#1129195 Filing: 000112534525000042 Input fundies:CapitalExpenditure: 3623000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534525000042/mgnx-20241231.htm#1136873 Filing: 000112534525000042 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 9.06 million Exact value Exact value: -9058000 USD 2023-01-01 – 2023-12-31: -9058000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2023-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -9058000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9058000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1659324 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	−USD 78.21 million Exact value Exact value: -78205000 USD 2023-01-01 – 2023-12-31: -78205000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2023-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -78205000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -78205000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1090350 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	USD 1.76 million Exact value Exact value: 1764000 USD 2023-01-01 – 2023-12-31: 1764000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2023-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 1764000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1764000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1097931 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	−USD 79.97 million Calculation and evidence -78205000 − 1764000 USD Exact free cash flow: -79969000 USD 2023-01-01 – 2023-12-31: -78205000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1764000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2023-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -79969000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -78205000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1090350 Filing: 000112534526000017 Input fundies:CapitalExpenditure: 1764000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1097931 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 66.97 million Exact value Exact value: -66966000 USD 2024-01-01 – 2024-12-31: -66966000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2024-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -66966000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -66966000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1658382 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	−USD 68.37 million Exact value Exact value: -68373000 USD 2024-01-01 – 2024-12-31: -68373000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2024-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -68373000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68373000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1089698 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	USD 3.71 million Exact value Exact value: 3706000 USD 2024-01-01 – 2024-12-31: 3706000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2024-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 3706000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3706000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1097341 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	−USD 72.08 million Calculation and evidence -68373000 − 3706000 USD Exact free cash flow: -72079000 USD 2024-01-01 – 2024-12-31: -68373000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 3706000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2024-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -72079000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -68373000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1089698 Filing: 000112534526000017 Input fundies:CapitalExpenditure: 3706000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1097341 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 74.62 million Exact value Exact value: -74620000 USD 2025-01-01 – 2025-12-31: -74620000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Net Income: -74620000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74620000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1657441 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	−USD 81.04 million Exact value Exact value: -81040000 USD 2025-01-01 – 2025-12-31: -81040000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Operating Cash Flow: -81040000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81040000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1089047 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	USD 1.91 million Exact value Exact value: 1914000 USD 2025-01-01 – 2025-12-31: 1914000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Capital Expenditure: 1914000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1914000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1096752 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.	−USD 82.95 million Calculation and evidence -81040000 − 1914000 USD Exact free cash flow: -82954000 USD 2025-01-01 – 2025-12-31: -81040000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 1914000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MACROGENICS, INC. · 2025-12-31 MACROGENICS, INC. (edgar:1125345) Free cash flow: -82954000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:43:51Z Snapshot: 2f6922dfca171ef21d871b1875781cae19a9753a3989e24090e3e6e7378b976a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125345?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -81040000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1089047 Filing: 000112534526000017 Input fundies:CapitalExpenditure: 1914000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000017/mgnx-20251231.htm#1096752 Filing: 000112534526000017 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

118 filings · 4,176 latest values · 4,176 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001125345, 1125345, MGNX, edgar:1125345

Also known as MACROGENICS INC, MACROGENICS, INC.

MACROGENICS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation